Physician profile
Lance E Templeton
NPI 1740253855
$4,481.20
in general payments reported to CMS, 2019-2025
35 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $460 · 2021: $872 · 2022: $528 · 2023: $774 · 2024: $494 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $791.93 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Abbvie INC. | $483.57 | 2020-2025 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $347.18 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $300.65 | 2019-2023 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $280.50 | 2023-2025 | Gemtesa |
| Antares Pharma, INC. | $230.29 | 2021-2022 | |
| Pfizer INC. | $216.25 | 2019-2024 | |
| Blue Earth Diagnostics | $176.82 | 2019-2025 | Posluma |
| Bayer Healthcare Pharmaceuticals INC. | $176.61 | 2019-2023 | |
| Allergan, INC. | $167.96 | 2019-2022 | |
| Coloplast Corp | $146.96 | 2019-2023 | Altis |
| Urovant Sciences INC | $123.82 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $105.72 | 2021-2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $91.67 | 2021-2023 | Pylarify |
| Neotract INC. | $79.75 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $75.69 | 2020 | |
| Tolmar, INC. | $74.14 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $72.90 | 2019-2020 | |
| Endo USA, INC. | $66.13 | 2024-2025 | Xiaflex |
| Acerus Pharmaceuticals Corporation | $58.39 | 2021-2022 | |
| Cook Medical LLC | $57.23 | 2019-2021 | |
| 180 Medical, INC. | $38.53 | 2019-2023 | Gentlecath Glide |
| Myovant Sciences INC. | $36.66 | 2021 | |
| Ferring Pharmaceuticals INC. | $36.55 | 2025 | Adstiladrin |
| Hollister Incorporated | $36.49 | 2022-2023 | Infyna Chic |
| Teleflex LLC | $30.65 | 2021-2024 | |
| Dendreon Pharmaceuticals LLC | $29.99 | 2025 | Provenge |
| Medtronic USA, INC. | $26.26 | 2019 | |
| Zyla Life Sciences, INC. | $22.06 | 2019 | |
| Procept Biorobotics Corporation | $21.57 | 2024 | Aquabeam System |
| Halozyme INC | $20.61 | 2023 | |
| Calyxo, INC. | $18.55 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $16.00 | 2023 | Spaceoar Vue System - 10ml |
| Olympus America INC. | $14.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Templeton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.